top of page
Insights for Life Sciences Talent Leaders
Strategic guidance on life sciences executive recruitment and human capital for search partners, biotech innovators, and scale-up HR leaders. I also share occasional personal reflections on the industry.


Q3 Pharma Earnings: Portfolio Renewal, Therapeutic-Area Concentration, and the Shift to Innovation-Led Growth
Q3 pharmaceutical results highlight a sector moving beyond pandemic-driven revenues toward innovation-led growth. Demand for obesity and specialty medicines is driving strong performance for companies with differentiated products, while mature and COVID-related portfolios continue to face pressure. Acquisitions and portfolio renewal are reshaping growth prospects, even as one-off costs can obscure underlying performance.
For life sciences leaders, this shift has implications
sharonshieldsconsu
Nov 95 min read


Bridging the Peaks and Valleys: Flexible Research Capability for Executive Search Firms
Executive search firms live with constant peaks and troughs in demand, creating pressure on research teams, margins, and delivery quality. This article explores how flexible research capability—blending strong in‑house teams with trusted external support—can help firms manage volatile workloads, protect consultant time, and maintain consistent standards without over‑hiring or risking burnout.
sharonshieldsconsu
Jul 274 min read


Fractional Roles in Life Sciences: A Smarter Way to Access Senior Talent
Fractional vs Interim in Life Sciences – Not the Same Thing
I’m seeing more life sciences organisations explore fractional senior roles – and they’re often confused with interim roles.
Interim: usually full‑time, time‑limited, covering a defined role for a fixed period.
Fractional: usually part‑time, longer-term, adding senior expertise for a set number of days or hours without owning the whole role.
In a milestone‑driven, resource‑constrained environment, fractional models
sharonshieldsconsu
Jul 112 min read
bottom of page